Results 241 to 250 of about 164,269 (359)

Serum osteocalcin is associated with the presence of hepatic steatosis in Chinese patients with chronic hepatitis B. [PDF]

Sci Rep
He Y, Tong L, Zhou Y, Xie F, Tian N, Xie W.   +5 more
europepmc   +1 more source

Non‐Nutritive Artificial Sweeteners Aspartame and Acesulfame‐K Ameliorate Metabolic Dysfunction‐Associated Steatotic Liver Disease in Male Ldlr−/− Mice

iNew Medicine, EarlyView.
ABSTRACT Aspartame and acesulfame‐K are commonly used non‐nutritive artificial sweeteners, but their impacts on cardiovascular disease and metabolic dysfunction‐associated fatty liver disease (MASLD) are unclear. In this study, we evaluated the impacts of aspartame and acesulfame‐K on MASLD and atherosclerosis in male Ldlr−/− mice fed an AMLN diet ...
Jingjing Xu, Xiaohua Jiang, Jianping Weng, Suowen Xu   +3 more
wiley   +1 more source

Assessing Hepatic Steatosis Following Weight Loss in Adolescents with Severe Obesity: A Randomized Controlled Trial. [PDF]

Children (Basel)
Talib A, De Boom F, Roebroek Y, Paulus GF, Koek G, Robben S, Winkens B, Bouvy N, van Heurn E.   +8 more
europepmc   +1 more source

Prospective Comparison of DWI‐Derived Virtual MR Elastography and Conventional MR Elastography in Metabolic Dysfunction‐Associated Steatotic Liver Disease and Healthy Volunteers

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Virtual MR elastography (VMRE) and MRE have been proposed for liver fibrosis staging in metabolic dysfunction‐associated steatotic liver disease (MASLD), but VMRE's diagnostic performance remains debated. Purpose To assess the inter‐visit and inter‐reader reproducibility of fat‐uncorrected and fat‐corrected diffusion‐weighted ...
Anton Volniansky, Thierry L. Lefebvre, Merve Kulbay, Guillaume Gilbert, Boyan Fan, Justine Racette, Emmanuel Montagnon, Damien Olivié, Giada Sebastiani, Jeanne‐Marie Giard, Marie‐Pierre Sylvestre, Bich Ngoc Nguyen, Guy Cloutier, An Tang   +13 more
wiley   +1 more source

FTO-mediated m6A demethylation of BECN1 mRNA promotes hepatic steatosis by impairing autophagy. [PDF]

BMC Immunol
Liu L, Ji B.
europepmc   +1 more source

Vibration‐controlled transient elastography in pediatric metabolic dysfunction‐associated steatotic liver disease

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a prevalent disease in children. Vibration‐controlled transient elastography (VCTE) offers a noninvasive alternative to liver biopsy, using controlled attenuation parameter (CAP) to estimate steatosis and liver stiffness measurement (LSM) for fibrosis.
Lauren B. Nichols, Sebastian G. J. Oakes, Cynthia Behling, Kathryn Harlow Adams, Mark H. Fishbein, Paula Hertel, Chao Jarasvaraparn, Jean P. Molleston, Marialena Mouzaki, Claude B. Sirlin, Miriam B. Vos, Laura A. Wilson, Stavra A. Xanthakos, Jeffrey B. Schwimmer, for the NASH CRN   +14 more
wiley   +1 more source

Chronic PET-Microplastic Exposure: Disruption of Gut-Liver Homeostasis and Risk of Hepatic Steatosis. [PDF]

Adv Sci (Weinh)
Park S, Kim MJ, Shin JH, Kim E, Son M, Lee S.   +5 more
europepmc   +1 more source

Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction‐associated steatotic liver disease treated with semaglutide: A case series

JPGN Reports, EarlyView.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects 30%–40% of youth with obesity and lacks approved pharmacologic therapies. In this single‐center retrospective case series at a tertiary care safety‐net children's hospital, we evaluated five adolescents (mean age: 17.0 years; 100% Hispanic; 60% male; mean body mass index:
Rachel Schenker, Katya Fomenko, Fotini T. Mitsinikos, Alaina P. Vidmar   +3 more
wiley   +1 more source

Adipocyte-specific deletion of gp130 prevents ketogenic diet-induced hepatic steatosis. [PDF]

Hepatol Commun
Senkalfa B, Gloor M, Podlaszewski R, Dewal RS, Horvath C, Efthymiou V, Ghosh A, Wueest S, Konrad D, Wolfrum C, Challa TD.   +10 more
europepmc   +1 more source

Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low - Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db / db Mice

, 2014
Amandine Everard, Sébastien Matamoros, Lucie Geurts, Nathalie M. Delzenne, Patrice D. Cani   +4 more
openalex   +1 more source